273 related articles for article (PubMed ID: 25550544)
21. Molecular targets for NF1-associated malignant peripheral nerve sheath tumor.
Binobaid L; Masternak MM
Rep Pract Oncol Radiother; 2020; 25(4):556-561. PubMed ID: 32494228
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives.
Prudner BC; Ball T; Rathore R; Hirbe AC
Neurooncol Adv; 2020 Jul; 2(Suppl 1):i40-i49. PubMed ID: 32642731
[TBL] [Abstract][Full Text] [Related]
23. Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1:
Tritto V; Ferrari L; Esposito S; Zuccotti P; Bianchessi D; Natacci F; Saletti V; Eoli M; Riva P
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31694342
[TBL] [Abstract][Full Text] [Related]
24. Advanced pharmacological therapies for neurofibromatosis type 1-related tumors.
Foiadelli T; Naso M; Licari A; Orsini A; Magistrali M; Trabatti C; Luzzi S; Mosconi M; Savasta S; Marseglia GL
Acta Biomed; 2020 Jun; 91(7-S):101-114. PubMed ID: 32608378
[TBL] [Abstract][Full Text] [Related]
25. Survival outcomes of malignant peripheral nerve sheath tumors (MPNSTs) with and without neurofibromatosis type I (NF1): a meta-analysis.
Lim Z; Gu TY; Tai BC; Puhaindran ME
World J Surg Oncol; 2024 Jan; 22(1):14. PubMed ID: 38191386
[TBL] [Abstract][Full Text] [Related]
26. Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.
Hirbe AC; Dehner CA; Dombi E; Eulo V; Gross AM; Sundby T; Lazar AJ; Widemann BC
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432242. PubMed ID: 38710002
[TBL] [Abstract][Full Text] [Related]
27. Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics.
Taylor Sundby R; Szymanski JJ; Pan A; Jones PA; Mahmood SZ; Reid OH; Srihari D; Armstrong AE; Chamberlain S; Burgic S; Weekley K; Murray B; Patel S; Qaium F; Lucas AN; Fagan M; Dufek A; Meyer CF; Collins NB; Pratilas CA; Dombi E; Gross AM; Kim A; Chrisinger JSA; Dehner CA; Widemann BC; Hirbe AC; Chaudhuri AA; Shern JF
medRxiv; 2024 Mar; ():. PubMed ID: 38293154
[TBL] [Abstract][Full Text] [Related]
28. Telomere erosion in NF1 tumorigenesis.
Jones RE; Grimstead JW; Sedani A; Baird D; Upadhyaya M
Oncotarget; 2017 Jun; 8(25):40132-40139. PubMed ID: 28454108
[TBL] [Abstract][Full Text] [Related]
29. The
White EE; Rhodes SD
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473354
[TBL] [Abstract][Full Text] [Related]
30. Elevated risk for MPNST in NF1 microdeletion patients.
De Raedt T; Brems H; Wolkenstein P; Vidaud D; Pilotti S; Perrone F; Mautner V; Frahm S; Sciot R; Legius E
Am J Hum Genet; 2003 May; 72(5):1288-92. PubMed ID: 12660952
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors.
Williams KB; Larsson AT; Keller BJ; Chaney KE; Williams RL; Bhunia MM; Draper GM; Jubenville TA; Rathe SK; Moertel CL; Ratner N; Largaespada DA
bioRxiv; 2024 Mar; ():. PubMed ID: 38585724
[TBL] [Abstract][Full Text] [Related]
32. Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI.
Ristow I; Kaul MG; Stark M; Zapf A; Riedel C; Lenz A; Mautner VF; Farschtschi S; Apostolova I; Adam G; Bannas P; Salamon J; Well L
Neurooncol Adv; 2024; 6(1):vdae021. PubMed ID: 38468867
[TBL] [Abstract][Full Text] [Related]
33. Neurofibromatosis type 1-associated plexiform neurofibromas of the neck: topography of lesions and surgical treatment data of 69 patients.
Friedrich RE; Löhmann DM
Oral Maxillofac Surg; 2024 Mar; 28(1):393-404. PubMed ID: 37173460
[TBL] [Abstract][Full Text] [Related]
34. Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.
Sun D; Xie XP; Zhang X; Wang Z; Sait SF; Iyer SV; Chen YJ; Brown R; Laks DR; Chipman ME; Shern JF; Parada LF
Cell Stem Cell; 2021 Aug; 28(8):1397-1410.e4. PubMed ID: 34010628
[TBL] [Abstract][Full Text] [Related]
35. Heterozygous NF1 dermal fibroblasts modulate exosomal content to promote angiogenesis in a tissue-engineered skin model of neurofibromatosis type-1.
Roy V; Paquet A; Touzel-Deschênes L; Khuong HT; Dupré N; Gros-Louis F
J Neurochem; 2023 Nov; 167(4):556-570. PubMed ID: 37837197
[TBL] [Abstract][Full Text] [Related]
36. Mandibular symmetry on posterior-anterior cephalograms of neurofibromatosis type 1 patients with facial plexiform neurofibroma.
Friedrich RE; Christ G; Scheuer HA
GMS Interdiscip Plast Reconstr Surg DGPW; 2023; 12():Doc11. PubMed ID: 38111842
[TBL] [Abstract][Full Text] [Related]
37. FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy.
Voigt E; Quelle DE
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686402
[TBL] [Abstract][Full Text] [Related]
38. Identification of growth hormone receptor in plexiform neurofibromas of patients with neurofibromatosis type 1.
Cunha KS; Barboza EP; Fonseca EC
Clinics (Sao Paulo); 2008 Feb; 63(1):39-42. PubMed ID: 18297205
[TBL] [Abstract][Full Text] [Related]
39. Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden.
Özden C; Mautner VF; Farschtschi S; Molwitz I; Ristow I; Bannas P; Well L; Klutmann S; Adam G; Apostolova I; Buchert R
J Neuroimaging; 2024; 34(1):138-144. PubMed ID: 37942683
[TBL] [Abstract][Full Text] [Related]
40. Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1.
Rozza-de-Menezes RE; Gaglionone NC; Andrade-Losso RM; Siqueira OHK; Almeida LM; Peruzini KDS; Guimarães-Filho MAC; Brum CI; Geller M; Cunha KS
Orphanet J Rare Dis; 2017 Dec; 12(1):186. PubMed ID: 29262839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
